The effects of tetracycline-loaded silk fibroin membrane on proliferation and osteogenic potential of mesenchymal stem cells

Journal of Surgical Research

Volumn 192, Issue 2, 2014, Pages E1-E9

  Jin, Seong Ho ^a   Kweon, HaeYong ^b   Park, Jun Beom ^a   Kim, Chang Hyen ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b National Institute of Animal Science   (South Korea)

Author keywords

Fibroins; Gingiva; Mesenchymal stromal cells; Multipotent stem cells; Silk; Tetracycline; Tissue engineering

Indexed keywords

4 CARBOXYGLUTAMIC ACID; BONE SIALOPROTEIN; CALCIUM; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA 1; OSTEOCALCIN; SILK FIBROIN; TETRACYCLINE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ARTIFICIAL MEMBRANE; FIBROIN; SILK;

ARTICLE; ARTIFICIAL MEMBRANE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DRUG RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; GINGIVA; MATERIALS TESTING; MESENCHYMAL STROMA CELL; PROCEDURES; TISSUE ENGINEERING;

ANTI-BACTERIAL AGENTS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; FIBROINS; GINGIVA; HUMANS; MATERIALS TESTING; MEMBRANES, ARTIFICIAL; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; SILK; TETRACYCLINE; TISSUE ENGINEERING;

EID: 84912073763     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.08.054     Document Type: Article

References (49)

1. Kellomäki M, Niiranen H, Puumanen K, Ashammakhi N, Waris T, Törmälä P. Bioabsorbable scaffolds for guided bone regeneration and generation. Biomaterials 2000;21:2495.
2. Danesh-Meyer MJ. Tissue engineering in periodontics and implantology using rhBMP-2. Ann R Australas Coll Dent Surg 2000;15:144.
3. Becker W, Dahlin C, Becker BE, et al. The use of e-PTFE barrier membranes for bone promotion around titanium implants placed into extraction sockets: a prospective multicenter study. Int J Oral Maxillofac Implants 1994;9:31.
4. Schwartzmann M. Use of collagen membranes for guided bone regeneration: a review. Implant Dent 2000;9:63.
5. Park YJ, Lee YM, Park SN, et al. Enhanced guided bone regeneration by controlled tetracycline release from poly(L-lactide) barrier membranes. J Biomed Mater Res 2000;51:391.
6. Bottino MC, Thomas V, Schmidt G, et al. Recent advances in the development of GTR/GBR membranes for periodontal regeneration-a materials perspective. Dent Mater 2012;28:703.
7. Altman GH, Diaz F, Jakuba C, et al. Silk-based biomaterials. Biomaterials 2003;24:401.
8. Wang Y, Kim HJ, Vunjak-Novakovic G, Kaplan DL. Stem cell-based tissue engineering with silk biomaterials. Biomaterials 2006;27:6064.
9. Foschi D, Corsi F, Cellerino P, Rizzi A, Morandi E, Trabucchi E. Angiogenic effects of suture biomaterials. An experimental study in rats. Eur Surg Res 2001;33:16.
10. Kurosaki S, Otsuka H, Kunitomo M, Koyama M, Pawankar R, Matumoto K. Fibroin allergy. IgE mediated hypersensitivity to silk suture materials. Nihon Ika Daigaku Zasshi 1999;66:41.
11. Setzen G, Williams EF. 3rd tissue response to suture materials implanted subcutaneously in a rabbit model. Plast Reconstr Surg 1997;100:1788.
12. Kasoju N, Bora U. Silk fibroin in tissue engineering. Adv Healthc Mater 2012;1:393.
13. Kundu B, Rajkhowa R, Kundu SC, Wang X. Silk fibroin biomaterials for tissue regenerations. Adv Drug Deliv Rev 2013;65:457.
14. Wenk E, Wandrey AJ, Merkle HP, Meinel L. Silk fibroin spheres as a platform for controlled drug delivery. J Control Release 2008;132:26.
15. Pritchard EM, Kaplan DL. Silk fibroinbio materials for controlled release drug delivery. Expert Opin Drug Deliv 2011;8:797.
16. Hofmann S, Foo CT, Rossetti F, et al. Silk fibroin as an organic polymer for controlled drug delivery. J Controlled Release 2006;111:219.
17. Goodson JM. Antimicrobial strategies for treatment of periodontal diseases. Periodontol 2000;1994:142.
18. Weinberg MA, Bral M. Tetracycline and its analogues: a therapeutic paradigm in periodontal diseases. Crit Rev Oral Biol Med 1998;9:322.
19. Walker CB, Pappas JD, Tyler KZ, Cohen S, Gordon JM. Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibilities to eight antimicrobial agents. J Periodontol 1985;56:67.
20. Gu Y, Walker C, Ryan ME, Payne JB, Golub LM. Nonantibacterial tetracycline formulations: clinical applications in dentistry and medicine. J Oral Microbiol 2012;4.
21. Chung CP, Kim DK, Park YJ, Nam KH, Lee SJ. Biological effects of drug-loaded biodegradable membranes for guided bone regeneration. J Periodontal Res 1997;32:172.
22. Jeong SH, Lee JE, Jin SH, Ko Y, Park JB. Effects of Asiasari radix on the morphology and viability of mesenchymal stem cells derived from the gingiva. Mol Med Rep 2014;10:3315.
23. Song JY, Kim SG, Lee JW, et al. Accelerated healing with the use of a silk fibroin membrane for the guided bone regeneration technique. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:e26.
24. Rahimi M, Mohseni-Kouchesfehani H, Zarnani AH, Mobini S, Nikoo S, Kazemnejad S. Evaluation of menstrual blood stem cells seeded in biocompatible Bombyx mori silk fibroin scaffold for cardiac tissue engineering. J Biomater Appl 2014;29:199.
25. Meinel L, Betz O, Fajardo R, et al. Silk based biomaterials to heal critical sized femur defects. Bone 2006;39:922.
26. Li Q, Wang J, Liu H, Xie B, Wei L. Tissue-engineered mesh for pelvic floor reconstruction fabricated from silk fibroin scaffold with adipose-derived mesenchymal stem cells. Cell Tissue Res 2013;354:471.
27. Ji W, Zhang Y, Hu S. Biocompatibility study of a silk fibroin-chitosan scaffold with adipose tissue-derived stem cells. Exp Ther Med 2013;6:513.
28. Meinel L, Karageorgiou V, Fajardo R, et al. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng 2004;32:112.
29. Meinel L, Karageorgiou V, Hofmann S, et al. Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res Part A 2004;71:25.
30. Jiang J, Hao W, Li Y, et al. Hydroxyapatite/regenerated silk fibroin scaffold-enhanced osteoinductivity and osteoconductivity of bone marrow-derived mesenchymal stromal cells. Biotechnol Lett 2013;35:657.
31. Chen L, Gu Y, Feng Y, et al. Bioactivity of porous biphasic calcium phosphate enhanced by recombinant human bone morphogenetic protein 2/silk fibroin microsphere. J Mater Sci Mater Med 2014;25:1709.
32. Fan Z, Zhang F, Liu T, Zuo BQ. Effect of hyaluronan molecular weight on structure and biocompatibility of silk fibroin/hyaluronan scaffolds. Int J Biol macromolecules 2014;65:516.
33. Kim IY, Jung UW, Kim CS, et al. Effects of a tetracycline blended polylactic and polyglycolic acid membrane on the healing of one-wall intrabony defects in beagle dogs. Biomed Mater 2007;2:S106.
34. Cheng CF, Wu KM, Chen YT, Hung SL. Bacterial adhesion to antibiotic-loaded guided tissue regeneration membranes - a scanning electron microscopy study. J Formos Med Assoc; 2013. http://dx.doi.org/10.1016/j.jfma.2013.07.010.
35. Jun HS, Seol YJ, Park YJ, Lee SJ, Rhyu IC, Chung CP. The effects of tetracycline loaded biodegradable membrane in experimentally induced periodontitis of beagle dogs. J Dent Res 2000;79:229.
36. Moses O, Nemcovsky CE, Tal H, Zohar R. Tetracycline modulates collagen membrane degradation in vitro. J Periodontol 2001;72:1588.
37. Lee SB, Lee DY, Lee YK, Kim KN, Choi SH, Kim KM. Surface modification of a guided tissue regeneration membrane using tetracycline-containing biodegradable polymers. Surf Interf Anal 2008;40:192.
38. Sipos PM, Loos BG, Abbas F, Timmerman MF, van der Velden U. The combined use of enamel matrix proteins and a tetracycline-coated expanded polytetrafluoroethylene barrier membrane in the treatment of intra-osseous defects. J Clin Periodontol 2005;32:765.
39. Zohar R, Nemcovsky CE, Kebudi E, Artzi Z, Tal H, Moses O. Tetracycline impregnation delays collagen membrane degradation in vivo. J Periodontol 2004;75:1096.
40. Moses O, Shemesh A, Aboodi G, Tal H, Weinreb M, Nemcovsky CE. Systemic tetracycline delays degradation of three different collagen membranes in rat calvaria. Clin Oral Implants Res 2009;20:189.
41. Wang Y, Morlandt AB, Xu X, Carnes DL Jr, Chen Z, Steffensen B. Tetracycline at subcytotoxic levels inhibits matrix metalloproteinase-2 and -9 but does not remove the smear layer. J Periodontol 2005;76:1129.
42. Duewelhenke N, Krut O, Eysel P. Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrob Agents Chemother 2007;51:54.
43. Wang Y, Wang WL, Xie WL, et al. Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/Akt activation. Phytomedicine 2013;20:787.
44. van de Loosdrecht AA, Beelen RH, Ossenkoppele GJ, Broekhoven MG, Langenhuijsen MM. A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Methods 1994;174:311.
45. Atala A, Lanza R. Handbook of stem cells. Academic Press; 2012.
46. Kaitila I, Wartiovaara J, Laitinen O, Saxen L. The inhibitory effect of tetracycline on osteogenesis in organ culture. J Embryol Exp Morphol 1970;23:185.
47. Saxen L. Tetracycline: effect on osteogenesis in vitro. Science 1965;149:870.
48. Park JB. Effects of doxycycline, minocycline, and tetracycline on cell proliferation, differentiation, and protein expression in osteoprecursor cells. J Craniofac Surg 2011;22:1839.
49. Gomes PS, Fernandes MH. Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells. Arch Oral Biol 2007;52:251.